<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03217461</url>
  </required_header>
  <id_info>
    <org_study_id>2017KYPJ056</org_study_id>
    <nct_id>NCT03217461</nct_id>
  </id_info>
  <brief_title>Corneal Epithelial Autograft for Limbal Dermoid</brief_title>
  <official_title>A Randomized Controlled Clinical Trial of Corneal Epithelial Autograft for Limbal Dermoid</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chunxiao Wang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to explore whether femtosecond laser-assisted corneal epithelial
      autograft is more effective than femtosecond laser-assisted limbal autograft for ocular
      surface reconstruction after excision of limbal dermoid.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 18, 2017</start_date>
  <completion_date type="Anticipated">December 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Restoration of corneal surface</measure>
    <time_frame>1 year</time_frame>
    <description>Restoration of a completely epithelized, stable, and avascular corneal surface.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cosmetic improvement</measure>
    <time_frame>1 year</time_frame>
    <description>A grading system from 0 to 4 with slit-lamp photographs will be used to determine cosmetic result of each graft.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal Thickness</measure>
    <time_frame>1 year</time_frame>
    <description>To measure corneal thickness using anterior segment optical coherence tomography.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>1 year</time_frame>
    <description>To measure best corrected visual acuity using ETDRS chart or Teller Acuity Cards.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal power, astigmatism and aberration</measure>
    <time_frame>1 year</time_frame>
    <description>To measure the changes of corneal power, astigmatism and aberration using autorefractor keratometer and wavefront aberrometer respectively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Density of stromal nerve and stromal keratocytes</measure>
    <time_frame>1 year</time_frame>
    <description>To assess the stromal nerve and stromal keratocytes using in vivo confocal microscopy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Corneal haze</measure>
    <time_frame>1 year</time_frame>
    <description>To assess corneal haze using in vivo confocal microscopy.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Corneal Dermoid</condition>
  <arm_group>
    <arm_group_label>Corneal epithelial autograft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Corneal dermoid tumor resection combined with femtosecond laser assisted corneal epithelial autograft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Limbal autograft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Corneal dermoid tumor resection combined with femtosecond laser assisted limbal autograft</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CorneaL epithelial autograft</intervention_name>
    <description>After removal of the recipient's diseased dermoid, a size-match donor epithelial tissue will be obtained from the healthy area of the same eye (corneal epithelial autograft) using femtosecond laser technology, with the goal of closure of bare stromal area by sutured corneal epithelial tissue to ensure the integrity of ocular surface. This closure may also create a microenvironment that stimulates stromal cells' regenerative capacity and regulates their epithelial-mesenchymal transition process.</description>
    <arm_group_label>Corneal epithelial autograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser</intervention_name>
    <description>A commercial femtosecond laser to create a particular shaped graft for transplantation</description>
    <arm_group_label>Corneal epithelial autograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Limbal autograft</intervention_name>
    <description>Simple dermoid excision will be performed, followed by closure of the bare sclera by sutured femtosecond laser-assisted limbal autograft.</description>
    <arm_group_label>Limbal autograft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Femtosecond laser</intervention_name>
    <description>A commercial femtosecond laser to create a particular shaped graft for transplantation</description>
    <arm_group_label>Limbal autograft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age between 1 to 30 years old;

          2. Patients with limbal dermoid, scheduled for elective surgical excision;

          3. Superficial lesion ranging from 5 to 9mm, without encroaching the deep stroma layer,
             as indicated by anterior segment optical coherence tomography images;

          4. Informed consent signed by a parent or legal guardian, or having the capability of
             understanding and signing the informed consent;

          5. Being able to comply with study assessments for the full duration of the study.

        Exclusion Criteria:

          1. Keratoconus;

          2. Ocular and facial active inflammation such as keratitis, trachoma, dacryocystitis,
             blepharitis, meibomian gland dysfunction, Sjogren's syndrome, cicatricial pemphigoid
             etc;

          3. High myopia with a spherical equivalent of -15.0 D or less;

          4. Corneal or ocular surface infection within 30 days prior to study entry;

          5. Ocular surface malignancy;

          6. Uncontrolled diabetes with most recent Hemoglobin A1c greater than 8.5%;

          7. Renal failure with creatinine clearance&lt; 25ml/min;

          8. Alanine aminotransferase &gt; 40IU/L, or aspartate aminotransferase &gt; 40IU/L;

          9. Platelet levels &lt; 150,000 or &gt; 450,000 per microliter;

         10. Hemoglobin &lt; 12.0 g/dL (male) or &lt; 11.0 g/dL (female);

         11. Prothrombin time &gt; 16s and activated partial thrombin time &gt; 35s in patients not
             accepting anticoagulant therapy; An international normalized ratio greater than 3 in
             patients accepting anticoagulant therapy;

         12. Pregnancy (positive test) or lactation;

         13. Participation in another simultaneous medical investigation or clinical trial;

         14. Severe cicatricial eye disease;

         15. Ocular comorbidities that affect the prognosis of transplantation, such as advanced
             glaucoma or retinal diseases;

         16. Severe dry eye disease as determined by Schirmer's test &lt; 2mm at least in one eye;

         17. Any medical or social condition that in the judgement of the investigator would
             interfere with or serve as a contraindication to adherence to the study protocol or
             ability to give informed consent;

         18. Signs of current infection, including fever and treatment with antibiotics;

         19. Active immunological diseases;

         20. History of allo-limbal transplantation, penetrating keratoplasty or anti-glaucoma
             filtering surgeries.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yizhi Liu, M.D.Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ting Huang, M.D.Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zhongshan Ophthalmic Center, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yingfeng Zheng, M.D.Ph.D.</last_name>
    <phone>+8613922286455</phone>
    <email>yingfeng.zheng@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Zhongshan Ophthalmic Center, Sun Yat-sen Univerisity</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yingfeng Zheng, M.D. Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 12, 2017</study_first_submitted>
  <study_first_submitted_qc>July 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 14, 2017</study_first_posted>
  <last_update_submitted>February 21, 2018</last_update_submitted>
  <last_update_submitted_qc>February 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Chunxiao Wang</investigator_full_name>
    <investigator_title>Clinical investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermoid Cyst</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

